Programme 2019

 10:00–11:30
 Conference hall 5
Broadcast
Infectious Diseases: How to Meet the UN Sustainable Development Goals by 2030? Panel session The contribution of healthcare to quality of life Although communicable diseases account for a smaller number of deaths in developed countries, they still result in substantial losses. In Russia, infectious diseases cause just 2% of deaths, but those who die are primarily young citizens of working age. The intensive migration of the population and developed tourism exacerbate this problem. As a result, new infections are appearing and old ones are making a return in new forms that are resistant to known drugs. According to WHO’s global plan for 2030, it is essential to end the AIDS epidemic, eliminate the hepatitis virus, and significantly reduce tuberculosis infection and mortality rates. In order to meet these challenges, it is vital to continuously monitor the situation, to intensively develop scientific research, and to put in place developed infrastructure and qualified staff, together with powerful prevention programmes and affordable drugs. How can the targets in WHO’s global plan be met in Russia? What problems must be overcome with respect to organizing the work of an infection control service and providing it with resources? Are there any new vaccines and drugs that could in principle have an impact on reducing mortality and illness caused by infectious diseases? How can hospital-acquired infections best be fought?
Moderator:
Guzel Ulumbekova — President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management
Head of the Higher School of Healthcare Organization and Management, Chairman of the Board of the Association of Medical Communities for the Quality of Medical Care and Medical Education.
Chairman of the Commission on Continuing Education of the National Medical Chamber, member of the Coordinating Council of the Ministry of Healthcare of Russia for Development of Continuing Medical and Pharmaceutical Education, member of the Board and Executive Secretary of the Russian Society for Healthcare Organization and Public Health.
Since 2003, she has been heavily involved in expert activities on healthcare organization at the Civic Chamber and the Chamber of Commerce and Industry of the Russian Federation, the State Duma Committee on Healthcare, the Strategic Research Centre of the Ministry of Economic Development of the Russian Federation, the WHO Council for Evidence-Based Medicine, etc.
Guzel Ulumbekova is the author of the books Russia’s Healthcare. What Needs to Be Done (2010) and Russia’s Healthcare. What Needs to Be Done-2 (2015) and a textbook for medical schools Public Health and Healthcare (2011); she is a contributor to and a member of the editorial board of the national guide Public Health and Healthcare (2013).
Panellists:
Marwan Akar — General Director, MSD Russia
Г-н Акар начал работу в MSD в качестве инженера-технолога производства. По мере развития карьеры он занимал разные должности с возрастающей сферой ответственности, руководил проектами по трансферу технологий производства вакцин и других лекарственных препаратов, способствовал наращиванию производственных мощностей MSD и компаний-партнеров по всему миру.
В 2008 году г-н Акар был назначен на пост руководителя операций производственного подразделения MSD в регионах «Восточная Европа, Ближний Восток и Африка» и «Европа и Канада». В этой роли он поддерживал стратегические проекты по развитию бизнеса, а также отвечал за партнерства с локальными производителями, в том числе в России.
Г-н Акар получил диплом магистра в Мэрилэндском университете (США) по специальности «Химик-технолог». Он также закончил обучение по программе МВА (Магистр делового администрирования) в Имперском колледже Лондона.
Oleg Dubyansky — Vice President, GSK Russia
Sergei Kraevoi — Deputy Minister of Healthcare of the Russian Federation
Born February 10, 1969 in Oryol Region. Graduated from the Military Medical Academy in 1983. Between 1989 and 2002, served in the USSR and Russian Federation Military, holding various positions in the medical field. In 2002-2003, led a scientific project for Novenergo LLC. 2003–2004: Depputy Director of the Zheldorpharmazeya of the Ministry of Communications. April to September 2013: acting CEO of RT-Biotechprom. Recipient of various awards and honorary diplomas, including an order For Excellent Service of the I-III degrees and a state award for development of the railway network. Holds a degree of doctor of medicine.
Decree No. 1640 of September12, 2013 appointed him Deputy Minister of Healthcare. Married, has a son and a daughter.
Vinay Patrick Saldanha — Director, Regional Support Team for Eastern Europe and Central Asia, UNAIDS
Mr. Vinay P. Saldanha is an international United Nations staff member
with more than two decades of professional experience in leadership
and implementation of AIDS programs, including more than 15 years
of work experience in countries of Eastern Europe and Central Asia.
In 1993 Mr. Saldanha pioneered one of the first HIV initiatives in St.
Petersburg, Russian Federation, to provide care and support to people
living with HIV. Later Mr. Saldanha became a political analyst for the
G8 Research Group, University of Toronto, focussing on the issue of HIV/AIDS and the role of the
Russian Federation during the G8 summit in Great Britain in 1998.
From 1998 to 2004 Mr. Saldanha served as Canadian project coordinator in the Canada AIDS Russia
Project (CARP) – an innovative interdisciplinary effort to unite leading Russian and Canadian
HIV/AIDS experts at the federal and regional level in training and research, as well as mobilising civil
society, funded by the Canadian International Development Agency.
Starting 2009, Mr. Saldanha served at UNAIDS headquarters in Geneva, first as Senior Executive
Officer to the Executive Director, and later as Deputy Chief of Staff of the EXO. Mr. Saldanha has been
engaged in planning the visits of UNAIDS Executive Director across the region of Eastern Europe and
Central Asia and accompanied Executive Director during his high-level visits all over the world.
Mr. Saldanha graduated with honours from the University of Toronto, majoring in political science and
English literature. Mr. Saldanha took postgraduate courses at the University of Toronto and the Institute
of World Politics in Washington, DC. He has also completed advanced training in HIV monitoring and
evaluation and global health. He is fluent in English and Russian.
Vladimir Uiba — Head, Federal Medical-Biological Agency of the Russian Federation
Front row participants:
Nikolay Briko — Head, Department of Epidemiology and Evidence-Based Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Melita Vujnovic — Representative to the Russian Federation, Head of Country Office in the Russian Federation, World Health Organization
Yury Lobzin — Children’s Clinical Research Centre for Infectious Diseases, Federal Biomedical Agency
Elena Malinnikova — Head, Department of Virology, Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
Vladimir Khristenko — President, Nanolek
 10:00–11:30
 Conference hall 8
Broadcast
Insurance Companies in Healthcare: For and Against Round table The contribution of healthcare to quality of life Healthcare can be funded by the state or by private wealth, including through voluntary medical insurance (VMI). State guarantees are paid via the budget and a system of compulsory medical insurance (CMI). Opinions differ as to the advantages of one system or the other, and every country must decide on its own solution. In Russia, CMI replaced the budgetary model more than 25 years ago. The money collected by CMI funds is allocated in accordance with established state law to medical institutions via private insurance companies. They are also responsible for monitoring the quality of healthcare, and for respecting and protecting the rights of the insured. Many experts believe, however, that these functions could be managed independently by CMI funds and the Federal Service for Surveillance in Healthcare (Roszdravnadzor). In other countries, the functions of insurance companies are far broader: they collect contributions and participate in the setting of tariffs, but, most significantly, they also bear the financial risks in the event of increased volumes of healthcare provision. For this reason, they have a direct interest in disease prevention and early detection. What model for financing state guarantees (budgetary or insurance-based) is optimal for Russia and why? What are the features of a fully-fledged CMI model? Who could shoulder the functions of insurance companies in the CMI sector? Could insurance representatives help patients? What are the prospects for voluntary medical and pharmaceutical insurance in the Russian Federation?
Moderator:
Nikolay Prokhorenko — Expert, All-Russian People's Front Central Headquarters; First Vice Rector, Graduate School of Healthcare Organization and Management
Panellists:
Andrey Abramov — Senior Vice President – Head, Voluntary Health Insurance Center, Business Development Unit, VSK
Alexander Grot — Vice President, All-Russian Non-Governmental Organization of Small and Medium-Sized Businesses Opora Russia
Born: May 25 1973, Moscow. Family: married, two daughters. Aleksander has graduated from Moscow Engineering Physics Institute (MEPhI) with a degree in applied mathematics. In 1997 he received a master's degree at the National Research University – Higher School of Economics (NRU-HSE). He has completed an Executive MBA program at Moscow State University in 2010. Education: Northeastern University (USA), Aoyama Gakuin University (Japan), OISE (Great Britain). Assumed office: President of the Medholding Group; President of Association of Private Clinics of Moscow and CFD (www.apcmed.ru); Vice-president of Association of private dental clinics (www.stomas.ru). Since 2010 Member of «Opora Russia», public organization of Small and medium-sized enterprises. Since 2012 Vice-president of non profit partnership «Opora Russia» Head of «Opora Russia» healthcare committee. Member of «Opora Russia» Moscow department, Head of «Opora Russia» Moscow social issues committee since 2010. Member of the Federal Antimonopoly Service (FAS) and the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Moscow branches public consultations councils. Head of healthcare work group for Moscow Civic Chamber committee on entrepreneurship. Member of FAS Expert council on promoting competition in the social sphere and healthcare. Member of joint NRU-HSE work group for gradual expanding of private sector participation in social services («Healthcare» area). Aleksander has received letters of acknowledgment from the Russian Ministry of Economic Development and the Ministry of Health.
Yury Zhulev — President, Russian Haemophilia Society
Dmitry Kuznetsov — Vice President, All-Russian Insurance Association
Mikhail Murashko — Head, Federal Service for Surveillance in Healthcare
Born on January 9, 1967 in Sverdlovsk.
1986-1988 – served in the USSR Army.
1992 – graduated from Ural State Medical Institute.
August 1992 – March 1996 – intern; Obstetrician Gynecologist, Komi Republic Hospital in Syktyvkar.
March 1996 – November 1996 – Deputy Medical Superintendent for Consulting and Diagnostics, Medical Superintendent, Komi Republic Perinatal Center in Syktyvkar.
November 1996 – December 1999 – Medical Superintendent, Komi Republic Medical Group in Syktyvkar.
January 2000 – March 2006 - Medical Superintendent, Komi Republic Perinatal Center under Komi Republic Agency of Health Care, Syktyvkar.
March 2006 – February 2011 – Minister of Health Care, Komi Republic.
February 2011 – June 2012 – Head of Department, Obstetrics and Gynecology Department (offers a course of pediatrics), Kirov State Medical Academy under the Ministry of health Care of the Russian Federation, Syktyvkar.
July 2012 – March 2013 – Deputy Head, Federal Service for Health Care Supervision, Moscow.
July 2013 – July 2015 – acting Head, Federal Service for Health Care Supervision.
July 14, 2015 till present time – Head of the Federal Service for Health Care Supervision (has the title of the Full State 2-nd Class Counsellor of the Russian Federation).
1999 – Doctor of Medicine.
2004 – postgraduate degrees in Obstetrics/Gynecology and Public Health Care Administration.
Board certified in Obstetrics/Gynecology and Public Health Care Administration.
Editor-in-Chief and Founder, Human Health in the North Journal. Editorial Board Member, Children’s Health Care in the North West Journal.
Nelly Naigovzina — Deputy Head, Analytical Center for the Government of the Russian Federation
Graduated from Kursk State Medical Institute. Doctor of Medical Sciences, Professor.
Ms. Naigovzina worked as a pediatrician, then headed up a ward and finally became deputy chief medical officer for patient treatment at the Tushino City Hospital for Children in Moscow.
1994 - 1996 - Head of Unit, Head of Directorate at the Federal Fund of Mandatory Medical Insurance
1996 - 1998 - Assistant to the First Deputy Chair of the Government of the Russian Federation V.V. Ilyushin, Deputy Chair of the Government of the Russian Federation O.N. Sysuev.
1998 - 1999 - Deputy Head of the Secretariat of the Deputy Chair of the Government of the Russian Federation V.I. Matvienko.
1999 - 2003 - Deputy Head of the Department for Social Development of the Administration of the Government of the Russian Federation.
2003 - 2008 - Deputy Head of the Expert Directorate of the President of the Russian Federation.
2008 - 2012 - Head of the Department for Social Development and Environmental Protection of the Government of the Russian Federation.
2012 - 2018 - Deputy Head of the Administration of the Government of the Russian Federation.
On 18 October, 2018 she was appointed as the Deputy Head of the Analytical Center.
Alla Pashkunova — Deputy Chairman, Council of Ministers of the Republic of Crimea
Leonid Roshal — President, National Medical Chamber
Roshal is the author and co-author of more than 250 scientific papers and seven books. His main areas of expertise are emergency surgery and traumatology, disaster medicine, and public health organization. He is President of the National Medical Chamber; the Head of the Department of Emergency Surgery and Traumatology of the Scientific Centre for Children's Health at the Russian Academy of Medical Sciences; a Member of the Presidential Council for the Promotion of Civil Society Institutions and Human Rights; the Chairman of the International Committee for Assistance to Children in Disasters and Wars; an Expert of the World Health Organization; a Member of the Board of Directors of the World Association for Disaster and Emergency Medicine; the President of the International Charitable Fund for Children in Disasters and Wars; and a Member of the World Federation of Associations of Pediatric Surgeons, the British Association of Paediatric Surgeons, and the World Association for Disaster and Emergency Medicine. He has been awarded Orders for Courage, Defender of a Free Russia, Merit to Moscow, Peter the Great (First Degree), the Revival of Russia. 21st Century, the Golden Cross, Glory to Russia, Saint Juliana of Lazarevo, Lomonosov, Golden Star of Glory, Pride of Russia, and the Nobel LUDVIG Prize 2010. He holds the titles: National Hero, Man of the Year 2002, Pride of Russia, and Russian of the Year. In 2005, he was granted the title of European of the Year. In 2007, he was nominated for the Nobel Peace Prize. Journalists awarded him the title Children's Doctor of the World in 1996.
Natalia Stadchenko — Chairman, Federal Mandatory Health Insurance Fund
Front row participants:
Sergey Plekhov — Deputy General Director, SOGAZ-Med Insurance Company
Andrey Ryzhakov — General Director, Alfastrakhovanie-OMS Ltd
Ruslan Khalfin — President, MAKS-M; Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
 10:00–11:30
 Conference hall 9
Broadcast
Federal Project ‘Fighting Cancer’: 85 Regional Approaches The contribution of healthcare to quality of life Fighting cancer is currently one of the government’s top priorities. Cancer is the second leading cause of death and ranks third in terms of the number of years of life lost in Russia. According to WHO, the number of oncological diseases has increased by roughly 15% over the last ten years, and cancer will be the top cause of death around the world over the next 5–7 years. The federal project ‘Fighting Cancer’ aims to reduce the mortality rate from tumours, including malignant tumours, to 185 cases per 100,000 people by 2024. In 2019, the regions will have to develop and launch regional programmes based on the specific issues they each face. What challenges do the regions face in developing specialized cancer programmes? What best practices can and should be used? What priorities should be set when developing programmes? What modern technologies can significantly increase effectiveness in preventing cancer?
Moderator:
David Melik-Guseinov — Director, Project Department, Ministry of Healthcare of the Russian Federation
Panellists:
Joao Breda — Head of the European Office for Prevention and Control of Noncommunicable Diseases, Programme Manager for Nutrition, Physical Activity, and Obesity, World Health Organization
Dr João Breda is head of the WHO European Office for the Prevention and Control of Noncommunicable Diseases (NCD), which is an integral part of the WHO Regional Office and its Division of NCD and Promoting Health through the Life-course. Launched in Moscow in 2014, the NCD Office marked an important milestone in the commitment made by the Russian Federation for combatting NCDs in the WHO European Region.
Before his appointment as head of the NCD Office in February 2017, during the past seven years Dr João Breda has been the Programme Manager: Nutrition, Physical Activity and Obesity at the Regional Office in Copenhagen, responsible for providing support to the 53 Member States of the WHO European Region on the implementation of the European Food and Nutrition Action Plan 2015-2020 and the Physical Activity Strategy for the WHO European Region 2016-2025, as well as evaluating their implementation process.
João Breda has a PhD in Nutritional Sciences from Porto University where he defended a thesis focused on alcohol abuse in young people. He completed his Master’s Degree in Public Health by the Faculty of Medical Sciences of Lisbon University and an MBA from the European University in Barcelona.
In Portugal, before joining WHO in 2010, João worked as a Public Health Specialist at the General Directorate of Health and other institutions of the Ministry of Health at local and central level, particularly in the fields of nutrition, physical activity, obesity and alcohol abuse. He was the first coordinator and led for several years the National Platform against Obesity.
As an academic, João chaired the Department of the Nutritional Sciences of Atlantic University (Lisbon). He also collaborated with Algarve University, Coimbra College of Agriculture and Coimbra Hospitality School.
Among his several dozens of published scientific papers and original books emerges the number one best-selling book on infant nutrition in Portugal.
Andrey Kaprin — Director, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Diana Kobesova — Chief Executive Officer, B2MED
Over 10 years of experience in national health-care project management.

Member of a working group in the State Institute of Drugs and Good Practices developing GMP legal framework for radiopharmaceutical production.

Since 2018: founder of the company B2MED (www.b2-med.ru) specializing in high-tech medical projects realization in Russia.

2013 – 2018: SEO, Board member of the “PET-Technology” network (joint project of the state corporation “RUSNANO” and private investors). In 5 years 11 PET/CT regional centers opened and the first radiopharmaceutical production in Russia using GMP standard built. 85 thousand PET/CT examinations conducted (65% of the PET/CT diagnostics volume in Russia). 1.5 thousand oncological patients saved by means of the country’s first therapy using the “CyberKnife” system. 90% of services are covered by CHI (compulsory health insurance) policy.

2008 – 2013: CFO of “Alpha - Health Center” network. 12 medical centers first opened in regions and a large-scale financial and economic service of the private medical network set up.
Sergei Levchenko — Governor of Irkutsk Region
Born in 1953 in Novosibirsk.
In 1976, he graduated from Department of Industrial and Civil Construction of V.V. Kuybishev Novosibirsk Engineering and Construction Institute. In 1993 – graduated from Department of Economics and Management of the Russian Management Academy of the Government of the Russian Federation.
He began his professional career in 1976 as foreman and then supervisor, head of division at Krasnoyarsk Construction and Installation Division of “Siberian Steel Structures” trust company.
1982 – 1987 – Head of Angarsk Construction and Installation Division of “Krasnoyarsk Steel Structures” trust company.
1987 – 1989 – Chairman of the South-West District Executive Committee of the city of Angarsk, Deputy of South-West District of the Soviet of People’s Deputies.
1988 – Second Secretary, and since 1990 – First Secretary of Angarsk City Committee of the Communist Party of the Soviet Union.
Since 1993 – First Secretary of Irkutsk Regional Division of the Communist Party of the Russian Federation.
1999 – 2003 – Deputy of the State Duma of the Federal Assembly of the Russian Federation of the third convocation, member of the Energy, Transport and Telecommunications Committee.
2004 – 2007 – Deputy of the Legislative Assembly of Irkutsk region, Chairman of Control Activity Commission.
2007-2011 – Deputy of the State Duma of the Federal Assembly of the Russian Federation of the fifth convocation, member of the Energy Committee.
2011 – 2015 – Deputy of the State Duma of the Federal Assembly of the Russian Federation of the sixth convocation, Deputy Chairman of the Energy Committee.
In 2014, he was awarded with the Letter of Recognition of the President of the Russian Federation.
On September 27, 2015, he won the early direct election of the Governor of Irkutsk Region.
On October 2, 2015, he official took the office of the Governor of Irkutsk Region.
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Alexander Roediger — Executive Director Oncology Policy, MSD Pharmaceuticals
Alexander Roediger (1968), Swiss and German, MA and Executive Master of Business Administration, leads Oncology Policy at MSD for Europe, Middle East, Africa and Canada (EMEAC). In his current role he focuses on Oncology policy, i.e. health system financing, pricing and reimbursement and innovation policies. He is currently Chair of the EFPIA Oncology Steering Committee as well as Chair of the Healthcare Committee of the American Chamber of Commerce to the EU.

He has a Master degree in Philosophy from the University of Zurich; in 2006 he received his Executive Master's Degree of Business Administration from the University of St. Gallen. Before joining MSD, he worked for UNICEF Switzerland and Helsana Insurances, a major health insurer in Switzerland.
Front row participants:
Nikolay Briko — Head, Department of Epidemiology and Evidence-Based Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Oleg Kit — General Director, Rostov Research Institute of Oncology of the Ministry of Healthcare of the Russian Federation
Chingis Mustafin — Doctor of Anti-Aging Medicine, Impedance Medical Technologies
Igor Khatkov — Chief Non-Staff Specialist Oncologist, Moscow City Healthcare Department
 12:00–13:30
 Conference hall 4
Broadcast
Reducing Mortality from Non-Communicable Diseases: Implementing Federal Projects Panel session The contribution of healthcare to quality of life Accredited by the Commission of the Coordinating Council for the Development of Continuing Medical Education The major non-communicable diseases are the leading cause of death in Russia and represent a heavy burden for the national economy. The key objectives of the Healthcare National Project are to reduce mortality from cancer and cardiovascular disease and to combat the spread of diabetes. In order to achieve this, outpatient cancer care centres will be created, regional vascular centres and primary vascular care departments will be refurbished, nuclear medicine centres have been built, a sufficient amount of drug therapy has been provided for oncological diseases, and large-scale preventive measures will be conducted. Are the measures envisaged by the Healthcare National Project sufficient to significantly reduce mortality, morbidity, and disability from major non-communicable diseases? What are the risks of implementing federal projects that aim to reduce mortality from cancer and cardiovascular diseases? Are there new breakthrough medications for the treatment and prevention of non-communicable diseases? What is the role of the population and municipal leaders in preventing common diseases?
Moderator:
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. She is married with two daughters.
Panellists:
Sergey Boytsov — Director, National Research Centre for Preventive Medicine of the Ministry of Health of the Russian Federation
Nikolay Briko — Head, Department of Epidemiology and Evidence-Based Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Pavol Dobrocky — Chief Executive Officer, Boehringer Ingelheim Russia
Andrey Kaprin — Director, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Andrey Potapov — Chief Executive Officer, Takeda Pharmaceuticals Russia
Aleksandr Rumyantsev — President, Dmitry Rogachev National Research Centre
Alexander Rumyantsev, born in 1947, is a Russian Doctor of Medical Sciences, professor, member of the Russian Academy of Sciences, General Director of the Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, member of the Board of the ‘Doctors, Innovation and Science for Children’ Foundation that supports the development of Pediatric Hematology, Oncology and Immunology, chief consulting pediatric hematologist of the Ministry of Health of Russia, President of the National Society of Pediatric Hematologists and Oncologists, Chairman of the Board of the National Association of Experts in Primary Immunodeficiency, Vice President of the National Medical Chamber, Honorary Professor of the Department of Oncology and Hematology of the School of Pediatrics of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. Graduated with honours from the Russian National Research Medical University named after N.I. Pirogov in 1971.
Alexander Rumyantsev is an active facilitator of medical science and practice. For years he headed the RSMU scientific programmes on leukemia in humans and animals of the USSR Committee for Science and Technology and research on rectifying the consequences of Chernobyl disaster, was a member of the Academic Council of the Academy of Medical Sciences and the Ministry of Health of the USSR on pediatrics, hematology and oncology. From 1989 to the present day he has been a Chairman of the hematology section of the Moscow Society of Pediatric Physicians. He is a participant of the Chernobyl nuclear disaster elimination team (1986–1987), ‘Children of Chernobyl’ research programme facilitator in the USSR (1990–1991) and in Russia (1991–1995). Rumyantsev for twenty five years has led pediatric hematology/oncology services in Russia, the process of preparation and adoption of the industry development and financing programme, successful treatment of leukemia, malignant lymphomas, brain tumours, other neoplasms in children and adolescents, setting up a course on pediatric hematology/oncology in the School of Continuing Medical Education in RSMU (the Department of Clinical Hematology/Oncology and Immunology of the School of Continuing Medical Education in RSMU since 2004, and the Department of Oncology and Hematology of the School of Pediatrics of the RSMU), the groundwork for academic programme, the training and certification of pediatric hematologists/oncologists in the Russian Federation.
As a researcher, Alexander Rumyantsev is known for his works in pediatric hematology and immunology, medical ecology, intensive and outpatient pediatrics, adolescent medicine and organization of public health, clinical physiology and pathophysiology of blood, regulation of hematopoiesis and immune response, pathogenesis and treatment of hereditary and evoked blood diseases in children, intensive polychemotherapy and immunotherapy of leukemia. Alexander Rumyantsev is the author of more than 650 scientific papers, including 45 monographs and manuals. He is a member of the Scientific Council and the head of the scientific platform ‘Oncology’ of the Ministry of Health of the Russian Federation, the editor-in-chief of the Bulletin of Blood Service in Russia journal, a member of editorial boards of the following journals: Pediatrics, Russian Pediatric Journal, Issues of Practical Pediatrics, Issues of Dietary Therapy In Pediatrics, Issues of Hematology/Oncology And Immunopathology In Pediatrics, Hematology And Transfusiology, Russian Journal of Pediatric Hematology and Oncology, School of Health, Russian Journal of Immunology; member of the Pharmaceutical Committee of the Russian Federation; member of the National Council of Experts on Rare Diseases, advised 70 doctors and 128 candidates of medical sciences. Honourable Laureate of the Russian National Research Medical University awards (1978, 1983, 1994, 2007), of the Maslov Academy of Medical Sciences of the USSR (1978), of the Moscow Komsomol (1979) for the research in hematology and immunology. He was awarded with a participant’s diploma and a silver medal of the VDNKh (All-Union Exhibition of Achievements of National Economy) (1989) for development of diagnostics and immunotherapy of blood diseases in children, and with an honorary medal of the University of Montpellier (France, 1990). In 1994 he was awarded the Order of Friendship of Peoples for his scientific and academic work, in 2002 – the Honorary Diplomas of the State Duma of the Russian Federation and the Moscow City Duma, in 2003 and 2015 – ‘The Calling’ Award for the best doctors in Russia, in 2004 – the medal ‘For Merits in Healthcare’, in 2007 – Excellent Worker of Public Health badge. In 2008 and 2011 he received the medical awards from the Moscow government, in 2013 – the International Galien Award. In 2015 he was awarded the Glory of Ossetia Order and the Russian Emergencies Ministry (EMERCOM) medal ‘Cooperation for Salvation’.
Married with two children and five grandchildren.
Oleg Salagay — Deputy Minister of Healthcare of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Marina Shestakova — Deputy Director, Endocrinology Research Centre of the Ministry of Health of the Russian Federation
Evgeniy Shlyakhto — Director General, Almazov National Medical Research Centre; President, Russian Society of Cardiology
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Oksana Barvinok — Co-Founder and Director for Marketing, EXPERT Сlinic
Matthias Wernicke — General Manager, Merck Biopharma Russia and CIS
Matthias holds a Master’s as well as Doctor’s degree in Economics from Oxford University, UK.
Before joining Merck, he was a Partner at McKinsey & Co in Berlin providing consulting services to customers from the pharmaceutical and healthcare industry.
Matthias joined Merck in 2014 as a European Head of Market Access & Pricing.
From June 2015 to September 2017, Matthias Wernicke was Managing Director of Merck Austria, based in Vienna.
In October 2017, Dr.Wernicke was appointed General Manager of Merck Biopharma Russia & CIS.
Vadim Vlasov — President, Novartis Group of Companies in Russia; Regional Director for Eastern and Central Europe and CIS, Novartis
Vadim Vlasov has been Country President of Novartis Group Russia since September 2010. In this role he is accountable for the local business operations management, interaction with external stakeholders, coordination of Novartis divisions and business units in Russia, the company reputation maintenance and development.
Prior to joining Novartis in 2003-2010 Mr. Vlasov occupied the position of Head of EADS/Airbus in Russia.
Previously, Mr. Vlasov served as Head of Siemens Medical Solutions and Country Manager of Acuson Corporation in Russia and CIS, worked in the Deputy Minister of Defense of the Russian Federation office.
Mr. Vlasov has a Degree of Mechanical Engineer (with honours) from Moscow Aviation Institute and completed Advanced Development Program at London and Harvard Business Schools.
Victoria Madianova — Director of the Department of International Health Projects, Higher School of Healthcare Management of the Institute of Leadership and Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Ekaterina Milova — Development Director, ORBI Anti-Stroke Foundation
Oksana Monge — General Director, Sanofi Russia
General Manager Sanofi Eurasia from October 1, 2018. Prior to that since January 1, 2016 worked as General Manager, Rx, Sanofi Russia & Belarus.
Engineer by training with MBA degree from Cranfield School of Management, UK, Oxana has got more than seventeen years of in-depth knowledge and experience in pharmaceutical industry with a number of leadership roles in Marketing, Strategic Planning, and Sales in Russia and UK.
Oxana started her career in pharmaceutical industry in 2001 with Eli Lilly UK. Over the following 13 years, she took on a number of senior management positions with increasing responsibility. In 2014, Oxana joined Sanofi as a Head of Diabetes BU in Russia.
Dmitry Morozov — General Director, BIOCAD
DOB: 01.02.1965 | POB: Moscow | Marital status: married, 3 children

In 2001 he founded BIOCAD CJSC, the leading Russian innovative biotechnology company of the full cycle, which is the leader on the Russian oncological market by the results of 2017.

AWARDS:
• Gratitude from the Committee for Industrial Policy and Innovation of St. Petersburg for conscientious work and strengthening the scientific and production potential of St. Petersburg;
• Appreciation of the Ministry of Industry and Trade of the Russian Federation for contribution to the development of the pharmaceutical and medical industry and long-term conscientious work;
• Gratitude from the Governor of St. Petersburg;
• Honorary sign "Investor of the Year" for the implementation of the best investment project in the sphere of industry in St. Petersburg;
• Prize of the Government of St. Petersburg for outstanding achievements in the field of higher and secondary vocational education in the nomination "In the field of integration of education, science and industry" for 2015;
• The Russian Government's Quality Award for achieving high results in the field of product and service quality and the introduction of high-quality methods of quality management for 2016;
• Member of the Subcommission on Drug Administration of the Government Commission for Health Protection;
• Member of the Expert Council for the Development of the Pharmaceutical Industry under the Ministry of Industry and Trade of Russia;
• Included in the Expert Council under the FAS Russia.

AWARDS 2017:
• St. Petersburg's "Investor of the Year" award for the implementation of the best investment project in the industry for 2017;
• The "TechUspech-2017" Prize;
• Joined the list of top managers in the pharmaceutical industry according to the version of the Top 100 project of the Delovoy Peterburg newspaper.
Yulia Rakovskaya — Federal Coordinator for the Sanitary and Preventive Education of the Population, Medical Volunteers
 12:00–13:30
 Conference hall 5
Broadcast
Overcoming Gaps in the Quality of Healthcare: Staff and Management Panel session The contribution of healthcare to quality of life Accredited by the Commission of the Coordinating Council for the Development of Continuing Medical Education According to experts, low-quality healthcare is the third largest cause of death in the US. These indicators may be equally worrying in Russia. This can be avoided consistently and systematically by implementing measures to ensure access to healthcare – especially in the primary healthcare system, where most episodes begin and end. The quality of care can be improved by increasing the level of qualifications earned by staff, implementing clinical recommendations, and creating a control system at all levels – from the national level down to specific organizations. The entire healthcare system is dependent on the effectiveness of primary healthcare. What challenges do the Healthcare and Demographics national projects pose for the medical training system? What skills will doctors need to possess by 2024? What is more effective in obtaining the best results from a practitioner – strict monitoring or positive motivation? How can information about healthcare quality be made as transparent as possible? How can staff shortages be overcome?
Moderator:
Igor Kagramanyan — First Deputy Chair, Committee on Social Policy, Federation Council of the Federal Assembly of the Russian Federation
Born on April 30, 1962 in Kaluga region.
In 1986 he graduated from the Yaroslavl Medical Institute with a degree "Doctor (general phisician)". From 1986 - 1991 went from doctor-intern to the head of department in the Yaroslavl regional clinical psychiatric hospital. 1994 - 2007 - Vice Rector of the Yaroslavl State Medical Academy. In 2000 graduated from the Yaroslavl State University with a degree "Lawyer".
In 2007 joined the Department of Health and Pharmacy Yaroslavl region, where he first held the position of the first deputy director of the department, then director of the department . PhD in economics. Was the recipient of numerous awards, including a medal "20years of the Soviet withdrawal from Afghanistan", "For Service to the Motherland» of 2-nd degree , "For the community in the name of salvation", the medal of the Ministry of Health of the Russian Federation "Excellent Health", badge of honor of the Governor of the Yaroslavl region "For his services in education - high school".
By Order of the Government of the Russian Federation on June 18, 2012 № 1007-r was appointed as Deputy Minister of Health of the Russian Federation.
Panellists:
Nelly Naigovzina — Deputy Head, Analytical Center for the Government of the Russian Federation
Graduated from Kursk State Medical Institute. Doctor of Medical Sciences, Professor.
Ms. Naigovzina worked as a pediatrician, then headed up a ward and finally became deputy chief medical officer for patient treatment at the Tushino City Hospital for Children in Moscow.
1994 - 1996 - Head of Unit, Head of Directorate at the Federal Fund of Mandatory Medical Insurance
1996 - 1998 - Assistant to the First Deputy Chair of the Government of the Russian Federation V.V. Ilyushin, Deputy Chair of the Government of the Russian Federation O.N. Sysuev.
1998 - 1999 - Deputy Head of the Secretariat of the Deputy Chair of the Government of the Russian Federation V.I. Matvienko.
1999 - 2003 - Deputy Head of the Department for Social Development of the Administration of the Government of the Russian Federation.
2003 - 2008 - Deputy Head of the Expert Directorate of the President of the Russian Federation.
2008 - 2012 - Head of the Department for Social Development and Environmental Protection of the Government of the Russian Federation.
2012 - 2018 - Deputy Head of the Administration of the Government of the Russian Federation.
On 18 October, 2018 she was appointed as the Deputy Head of the Analytical Center.
Dmitry Pushkar — Chief Urologist, Ministry of Healthcare of the Russian Federation; Head of the Department of Urology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Education: in 1986, graduated with distinction from the Therapeutic Department of Moscow Institute of Medicine and Dentistry. Subsequently did post graduate studies, specialising in Urology in Moscow, Germany, France and the USA.
He is the sole Russian urologist certified by the Higher European Urological Commission.
He has performed the largest number of urological reconstructive plastic surgery operations in women.
He has the most experience of performing surgical treatment of prostate cancer in the Russian Federation, including over one thousand robot-assisted radical prostatectomies.
2011: President of the European Academy of Urology.
Since 2010, in conjunction with leading engineers, had been developing a Russia robot-surgery complex.
Prof. Pushkar regularly performs demonstration operations and gives topical courses in Europe and the USA.
He is the author of over 1000 scientific articles and 50 monographs in Russia and abroad.
Leonid Roshal — President, National Medical Chamber
Roshal is the author and co-author of more than 250 scientific papers and seven books. His main areas of expertise are emergency surgery and traumatology, disaster medicine, and public health organization. He is President of the National Medical Chamber; the Head of the Department of Emergency Surgery and Traumatology of the Scientific Centre for Children's Health at the Russian Academy of Medical Sciences; a Member of the Presidential Council for the Promotion of Civil Society Institutions and Human Rights; the Chairman of the International Committee for Assistance to Children in Disasters and Wars; an Expert of the World Health Organization; a Member of the Board of Directors of the World Association for Disaster and Emergency Medicine; the President of the International Charitable Fund for Children in Disasters and Wars; and a Member of the World Federation of Associations of Pediatric Surgeons, the British Association of Paediatric Surgeons, and the World Association for Disaster and Emergency Medicine. He has been awarded Orders for Courage, Defender of a Free Russia, Merit to Moscow, Peter the Great (First Degree), the Revival of Russia. 21st Century, the Golden Cross, Glory to Russia, Saint Juliana of Lazarevo, Lomonosov, Golden Star of Glory, Pride of Russia, and the Nobel LUDVIG Prize 2010. He holds the titles: National Hero, Man of the Year 2002, Pride of Russia, and Russian of the Year. In 2005, he was granted the title of European of the Year. In 2007, he was nominated for the Nobel Peace Prize. Journalists awarded him the title Children's Doctor of the World in 1996.
Gennady Suhih — Director, Kulakov National Medical Research Centre for Obstetrics, Gynaecology, and Perinatology of the Ministry of Health of the Russian Federation
Ruslan Khalfin — President, MAKS-M; Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Vladimir Chekhonin — Vice President, Russian Academy of Sciences; Head of the Department of Medical Nanobiotechnology of Medical and Biological Faculty, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation
Vladimir Chekhonin, born 1959.
1975-1981 studied and graduated from the Therapeutic faculty of Pirogov Russian National Research Medical University. In 1984 received a PhD (Candidate of Sciences Degree) the Biochemistry Department of the same University.
My career at the Pirogov University began with the position of junior fellow at the
Problem Laboratory for Immunochemistry of Malignant and Embryonic Tissues at the Biochemistry Department.
Since 1986 my work has been connected with the Serbsky State Scientific Center for Social and Forensic Psychiatry. At the Center, I worked as senior fellow, leading the immunochemistry group and Head of the Immunochemistry Lab. Currently working as Director of the Department of Fundamental and Applied Neurobiology at the Serbsky Center.
In 1989 I received a Doctoral Degree (Doctor of Sciences) in Biochemistry. Graduated from the International school of Neuroscience (Padova, Italy) in 1992. In 1993 I was awarded the title of Professor of Biochemistry by the Higher Attestation Commission of Russia.
Elected corresponding member of the Russian Academy of Medical Sciences in 2002, became full member in 2005. Since 2011 – Secretary Academician of the Medical and Biological Department of the Russian Academy of Medical Sciences.
In 2008 founded the Department of Medical Nanobiotechnologies at the Russian State Medical University.
Since 2013 – member of the Russian Academy of Sciences and member of the RAS Presidium.
Elected Vice-President of the Russian Academy of Sciences in 2017.
Over 350 research publications, including 23 inventions and patents in Russia and 7 monographs published in Russia and abroad.
Awards
Laureate of the Pirogov Russian National Research Medical University Gulevich Prize for the best paper on Biochemistry and Medical Chemistry
Medal of the Order ‘For Merit to the Fatherland’, II class (2001)
Honoured Scholar of the Russian Federation (2007)
Badge for Contributions to Healthcare (2013)
Gold Medal of Pirogov Russian National Research Medical University (2015)
Front row participants:
Tatyana Vladimirova — Medical Director, Abbott Russia
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Tatyana Semenova — Director, Department of Medical Education and Personnel Policy in Healthcare, Ministry of Health of the Russian Federation
Anna Solovyeva — Head, Department of Dentistry and Dental Care, Medsi Group Medical Academy; Chief Specialist for Dentistry, Medsi Group
 12:00–13:30
 Conference hall 6
Broadcast
The Digitalization of Healthcare: Investing to Save Lives Panel session The contribution of healthcare to quality of life Within the context of the project to create a single digital framework based on the Unified State Healthcare Information System, it is planned that a fully-fledged information system will be implemented in each of Russia’s 85 regions in accordance with uniform criteria. The complete digitalization of Russian healthcare will make it possible to accelerate the processes that take place within medical organizations, transfer the necessary information together with patients, and organize consultations without time and geographical limitations. Great hope is placed on the application of artificial intelligence technology in medicine, which will, in the near future, facilitate the transition to high-precision and individualized medicine. All this will change the face of healthcare and make it more effective. What role will medical organizations and regions play in the project to create a single digital framework? What stage has the development of highly intelligent medical technologies reached in Russia? How will full digitalization transform the healthcare provision system today and in the near future?
Moderator:
Dmitry Peskov — Special Representative of the President of the Russian Federation on Digital and Technological Development
Panellists:
Danil Baryshnikov — Chairman, Committee for Investment in Social Infrastructure, Agency for Social Investment
Elena Boyko — Deputy Minister of Healthcare of the Russian Federation
Elena Boyko graduated from Novosibirsk State Technical University; in 2005 she completed professional retraining within the Federal Programme for the Training of Management Personnel for National Economy Organizations of the Russian Federation; in 2011 she completed the Master of Business Administration programmme at Antwerp Management School, Belgium.
Previously, she was Deputy Director of the Department of State Policy for Informational Support of the State Authorities of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation, where she was responsible for the development of medical services on the State and Public Services Portal within the Unified State Health Information System (EGISZ).
Categories: director; IT and Communications Department.
Mark Zavadskiy — Vice President, Head of the SberX Ecosystem Development Division, Sberbank
Mark S. Zavadskiy was born on July 27, 1977, in Moscow.In 2003, he graduated from Institute of Asian and African Studies of Moscow State University.
In 2003-2013 Zavadskiy worked as a journalist, covering China and Asia regions. From 2003 to 2007 he held the position of Chief Hong Kong Bureau at RIA Novosti.
In 2007-2013, he worked with the Expert Weekly. From 2012 to 2013, he was Head of Asia Bureau at Russia Beyond the Headlines. In 2012-2014, Mark Zavadskiy became the founder and CEO of the consulting and PR agency at Asia To Go Limited (Hong Kong). From 2014 to 2015, he held the position of Business Development Director for Russia and CIS markets at AliExpress.In 2015-2018, he was appointed CEO for Russian office AliExpress at Alibaba.com (RU), (Alibaba Group). In April 2018 Zavadskiy was appointed Vice-President at Sberbank, responsible for strategic partnerships with leading Russian and international digital companies. Since July 2018 Mark S. Zavadskiy became a director, Sberbank group ecosystem development department(Sber X).
Kirill Kaem — Senior Vice-President for Innovations, Skolkovo Foundation
Kirill Kaem, whose family have been doctors for no fewer than seven generations, graduated from the Kirov State Medical Academy in Nizhny Novgorod in 1992. Five years later he graduated with distinction from the economics department at the Lobachevsky State University, after successfully completing his studies in Russia and the USA on an MBA program run jointly with Taylor University. He has over 20 years' experience in senior management roles, including 15 years as a CEO at the corporation's various international branches. He specializes in launching start-ups in new regions and countries, and new business areas at major firms. From 1992 to 1994 he owned his own business, distributing medical equipment and pharmaceuticals. In 1995 Kirill Kaem set up a network of regional outlets for the Swedish company Oriflame in the Volga Region, which helped it become one of the region's biggest tax-payers. In the year 2000 he began working in Germany, in the central office of the company Varta. After Varta's merger with the American group Spectrum Brands, he spent eight years in overall charge of the company's operations in Russia. In 2008 he relaunched the German and American holding JAFRA International in Russia, improving profit margins by 40%. In 2009 he took control of the Russian holding Hygiene Kinetics, the biggest manufacturer in the market for domestic paper and cellulose products. Within two years the company's sales growth was several times higher than average growth in the sector, thanks to the introduction of new technologies. From 2011 to 2013 he headed up a new area of business at 'Alpha Group' - the biggest federal chain of clinics, 'Alpha Health Centre', where in the space of a year he managed to double revenue, whilst the chain itself saw profits rise by over a third. From 2013 onwards he has been a member of the Board of Directors and a co-founder of the international medical centre 'Medcluster', set up at the initiative of Sberbank in partnership with Strategy Group Partners, with Johns Hopkins Medicine International as a potential partner. From 2013-2017 he was director of the Skolkovo Foundation’s biomed cluster.
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology; Cardiologist; Member, Russian Academy of Sciences
Cardiologist; Corresponding Member of the Russian Academy of Sciences; Deputy Director for Science and Research, University Clinic of the Lomonosov Moscow State University; Board Member, Chairman of the Committee for International Cooperation, Russian Society of Cardiology; Adjunct Professor, Moscow Institute of Physics and Technology.
In 1994, graduated from the Academic and Teaching Personnel Training Faculty of the Moscow Sechenov Medical Academy with honours
1997 to 1999, worked at the Institute of Clinical Physiology, National Research Council of Italy; he has a diploma of the University of Pisa and of the Sant'Anna School of Advanced Studies. In 2000, he did an internship at Harvard University.
In 2001, received the European Cardiologist diploma from the European Union of Medical Specialists and the European Society of Cardiology. In 2003, elected Fellow of the European Society of Cardiology (ESC); in 2005 — Fellow of the American College of Cardiology
In 2005, awarded the Marie Curie Medal of the French Academy of Sciences for his research in cellular and molecular mechanisms of myocardial hypoxia in ischaemic heart disease and their correction by gene and cellular regenerative therapy.
In 2007, awarded the title of Full Professor of Cardiology. In 2012, Laureate of the Government of the Russian Federation’s Prize for Science and Technology.
Since 2013, Member of the ESC Education Committee; since 2014, Member of ESC Committees for Educational Projects, Certification and Accreditation, and International Relations; since 2015 — Member of working groups for standard development at the European Association of Cardiovascular Imaging and Heart Failure Association of the ESC.
Since 2014, member of the Board of Educational Programmes of the Russian Society of Cardiology, member of the working group on development of the Professional Standard for a Doctor of the Russian Federation Specializing in Cardiology.
In 2016, he was elected Russian Academy of Sciences Corresponding Member in fundamental medicine.
He is an expert in acute heart failure, ischaemic heart disease, cardiovascular imaging, heart valve pathology, transcatheter interventions, digital medicine, interdisciplinary translational research. He is a member of editorial committees of leading professional journals, co-ordinator and member of programme committees of cardiological congresses in Russia, European Countries and the USA. Actively involved in public activities.
He is currently actively engaged in development and implementation in Russia of a new fundamental and clinical discipline known as cardio-oncology, aimed at evaluation of the cardiovascular status of oncological patients and individuals cured of cancer, and early diagnosis and prevention of malignant tumour treatment complications.
Oleg Ovsyanitsky — General Director, VSK
Irina Panarina — General Manager, AstraZeneca Russia and Eurasia
Since May 2017 Irina Panarina has been appointed to the position of General Manager of AstraZeneca, Russia and Eurasia. Irina is responsible for AstraZeneca business in Russia & Eurasia Area and she leads AstraZeneca Russia.
Irina Panarina has worked for AstraZeneca since 2009. In October 2015 Irina joined the Russian team as Cardiovascular and Metabolic Disease Business Unit Head. Before coming to Russia, Irina Panarina held the position of General Manager at AstraZeneca Ukraine.
Prior to joining AstraZeneca Irina held regional roles at GSK Pharma headquarters in London, UK.
Irina Panarina has work experience in marketing, product portfolio management, people development.
Irina Panarina has degrees from Newcastle University & South Bank University. She also holds MBA degree from INSEAD Business School.
Arkady Stolpner — Chairman of the Board, Sergey Berezin Medical Institute
Born March 28, 1958 in Leningrad.
In 1982 Graduated Leningrad’s First Medical Institute named after Pavlov with a major in Medicine.
Completed a post graduate course in VNIIFK in Leningrad in 1987.
In 1990 graduated Shenyang Medical Institute in China with a degree in Oriental Medicine for foreigners.
Since 1991 remained on senior staff of various hi-tech retail and R&D companies.
Became CEO of LDC MIBS in 2003 and currently oversees all the innovative projects in the company. The list of company’s projects includes:
Largest MRI network in Russia.
Largest telemedical network.
Center for radiosurgery and radiotherapy.
World-class athlete in rowing. Married, raised a daughter and two sons.
Front row participants:
Eric Brovko — Founder and Investor, My Health platform; Deputy Chairman, Commission on Innovations and Informatization in Healthcare, Public Council of the Ministry of Health of the Russian Federation
Vladimir Lishchuk — Vice President, Academy of Medical and Technical Sciences
Sergey Morozov — Chief Freelance Diagnostic Specialist, Moscow Healthcare Department; Chief Executive Officer, Scientific and Practical Clinical Centre for Diagnostics and Telemedicine Technologies of Moscow Healthcare Department; Doctor of Medicine, Professor
Oleg Pak — Deputy Minister of Digital Development, Communications and Mass Media of the Russian Federation
Nikolay Sivak — Commercial Director, Philips "Healthcare" Russia and CIS
Claudio Franceschi — Director, Research Laboratory of System Medicine for Healthy Ageing, Lobachevsky State University of Nizhny Novgorod; Professor Emeritus of Immunology, University of Bologna
Professor Claudio Franceschi graduated from the University of Bologna (Italy) with honors in 1967 with a degree in medicine. He worked as a professor of immunology at the Universities of Padua (1980-86), Modena (1986-1998) and Bologna from 1998 to October 2013. Currently he is Professor Emeritus at the University of Bologna and a member of the Institute of Neurological Sciences of Bologna. Professor Franceschi is the founder of the interdepartmental Luigi Galvani research center at the University of Bologna (Director from 2001 to 2006). He held the position of Dean of the Faculty of Experimental Pathology of the University of Bologna (2010-2012). He was the scientific director of the Italian National Research Center on Aging (1996-2005). Professor Franceschi is the author of more than 720 articles in peer-reviewed journals, the citation index for Scopus is 40,982, the Hirsh index is 95. From 2018, he is the head of the laboratory of systemic medicine of healthy aging at Lobachevsky, Nizhny Novgorod, the Leading Scientist - Principal Investigator of the megagrant "Digital Personalized Healthy Aging Megagrant (CPM-Aging): Network Analysis of Large Multi-Content Data to Search for New Diagnostic, Predictive, and Therapeutic Goals".
 14:30–16:00
 Conference hall 4
Broadcast
A System of Universal Medicine Provision: Key to Achieving the National Goal Panel session The contribution of healthcare to quality of life Accredited by the Commission of the Coordinating Council for the Development of Continuing Medical Education Achieving life expectancy of 78 by 2024 is a multifaceted challenge, dependent to equal degrees on the population’s income level, lifestyle, and on the effectiveness of the healthcare system. Largely thanks to a system of medicine provision, developed countries have mostly succeeded in increasing life expectancy over the last 20 years. In Russia, access to free drugs through doctors’ prescriptions is today enjoyed only by those citizens who receive social benefits or who suffer from specific illnesses. Government expenditure in Russia is three times lower in this respect than in European Union countries with a similar level of economic development. Implementing a system of universal medicine provision will help to stop serious illnesses from getting worse and leading to complications, reduce the use of more long-term forms of healthcare, and have a positive impact on social attitudes. How much needs to be spent on medicine supply on a national scale? What is the government’s role in this expenditure? What should the implementation of a universal medicine provision system begin with? How can long-term medicine needs be determined? Are there provisions for reducing the costs of medicinal products by increasing the volume of public procurement?
Moderator:
Guzel Ulumbekova — President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management
Head of the Higher School of Healthcare Organization and Management, Chairman of the Board of the Association of Medical Communities for the Quality of Medical Care and Medical Education.
Chairman of the Commission on Continuing Education of the National Medical Chamber, member of the Coordinating Council of the Ministry of Healthcare of Russia for Development of Continuing Medical and Pharmaceutical Education, member of the Board and Executive Secretary of the Russian Society for Healthcare Organization and Public Health.
Since 2003, she has been heavily involved in expert activities on healthcare organization at the Civic Chamber and the Chamber of Commerce and Industry of the Russian Federation, the State Duma Committee on Healthcare, the Strategic Research Centre of the Ministry of Economic Development of the Russian Federation, the WHO Council for Evidence-Based Medicine, etc.
Guzel Ulumbekova is the author of the books Russia’s Healthcare. What Needs to Be Done (2010) and Russia’s Healthcare. What Needs to Be Done-2 (2015) and a textbook for medical schools Public Health and Healthcare (2011); she is a contributor to and a member of the editorial board of the national guide Public Health and Healthcare (2013).
Panellists:
Igor Vasiliev — Governor of Kirov Region
Igor Vasiliev was born on May 31, 1961 in Leningrad.
In 1983, he graduated from Leningrad State University and, in 2003, from Moscow State University.
After serving in the armed forced from 1983 to 1992, from 1992 to 2003 he worked in commercial structures.
In 2003 and 2004, Igor headed up the investment department of the Central Executive Committee of the United Russia party.
From 2004 to 2010, he represented the Republic of Komi in the Council of the Federation. He was a member of the Council of the Federation Committees on the financial markets and money circulation and on affairs of the north and small peoples and was Vice-Chairman of the Council of the Federation Commission for collaboration with the Russian Federation Accounts Chamber.
From 2010 through 2013, he was an auditor of the Accounts Chamber of the Russian Federation.
Married, with a daughter.
Elena Maksimkina — Director of Medicine Assistance and Medical Products Revision Regulation Department, Ministry of Healthcare of the Russian Federation
Born on 16 February 1961 in Moscow
Expert in pharmaceutical economics and management, Doctor of Pharm. Sciences (2005), Professor (2007).
In 1984 she graduated with honours from the Department of Pharmacy of the First Moscow Medical Institute. Since 1984, she worked at Sechenov First Moscow State Medical University in various capacities, including as a dean of the department of pharmaceutical postgraduate studies from 2005 to 2011 and the head the department of the pharmaceutical economics and management since 2007.
She is experienced in regulatory and expert support of pharmaceutical operations licensing and the development of specific standard operating procedures for the medicines circulation.
She is the author of the first marketing research thesis of the Russian pharmaceutical market (1993); she scientifically proved the reasons for the implementation of a new institutional economics paradigm (NIEP) to interpret the patterns of the pharmaceutical market (2005). Her research focuses on the institutional foundations of the development and operation of the Russian pharmaceutical market self-regulation, various aspects of pharmaceutical marketing, industry financial management, competitiveness of pharmaceutical organisations, organisational context of pharmaceutical quality assurance. In total, she has more than 160 publications. She academically advised eight Candidate of Sciences and one PhD dissertations.
Since 2007 she is a member of the International Pharmaceutical Federation (FIP) and participant of annual international conferences.
Oksana Monge — General Director, Sanofi Russia
General Manager Sanofi Eurasia from October 1, 2018. Prior to that since January 1, 2016 worked as General Manager, Rx, Sanofi Russia & Belarus.
Engineer by training with MBA degree from Cranfield School of Management, UK, Oxana has got more than seventeen years of in-depth knowledge and experience in pharmaceutical industry with a number of leadership roles in Marketing, Strategic Planning, and Sales in Russia and UK.
Oxana started her career in pharmaceutical industry in 2001 with Eli Lilly UK. Over the following 13 years, she took on a number of senior management positions with increasing responsibility. In 2014, Oxana joined Sanofi as a Head of Diabetes BU in Russia.
Dmitry Morozov — General Director, BIOCAD
DOB: 01.02.1965 | POB: Moscow | Marital status: married, 3 children

In 2001 he founded BIOCAD CJSC, the leading Russian innovative biotechnology company of the full cycle, which is the leader on the Russian oncological market by the results of 2017.

AWARDS:
• Gratitude from the Committee for Industrial Policy and Innovation of St. Petersburg for conscientious work and strengthening the scientific and production potential of St. Petersburg;
• Appreciation of the Ministry of Industry and Trade of the Russian Federation for contribution to the development of the pharmaceutical and medical industry and long-term conscientious work;
• Gratitude from the Governor of St. Petersburg;
• Honorary sign "Investor of the Year" for the implementation of the best investment project in the sphere of industry in St. Petersburg;
• Prize of the Government of St. Petersburg for outstanding achievements in the field of higher and secondary vocational education in the nomination "In the field of integration of education, science and industry" for 2015;
• The Russian Government's Quality Award for achieving high results in the field of product and service quality and the introduction of high-quality methods of quality management for 2016;
• Member of the Subcommission on Drug Administration of the Government Commission for Health Protection;
• Member of the Expert Council for the Development of the Pharmaceutical Industry under the Ministry of Industry and Trade of Russia;
• Included in the Expert Council under the FAS Russia.

AWARDS 2017:
• St. Petersburg's "Investor of the Year" award for the implementation of the best investment project in the industry for 2017;
• The "TechUspech-2017" Prize;
• Joined the list of top managers in the pharmaceutical industry according to the version of the Top 100 project of the Delovoy Peterburg newspaper.
Mikhail Murashko — Head, Federal Service for Surveillance in Healthcare
Born on January 9, 1967 in Sverdlovsk.
1986-1988 – served in the USSR Army.
1992 – graduated from Ural State Medical Institute.
August 1992 – March 1996 – intern; Obstetrician Gynecologist, Komi Republic Hospital in Syktyvkar.
March 1996 – November 1996 – Deputy Medical Superintendent for Consulting and Diagnostics, Medical Superintendent, Komi Republic Perinatal Center in Syktyvkar.
November 1996 – December 1999 – Medical Superintendent, Komi Republic Medical Group in Syktyvkar.
January 2000 – March 2006 - Medical Superintendent, Komi Republic Perinatal Center under Komi Republic Agency of Health Care, Syktyvkar.
March 2006 – February 2011 – Minister of Health Care, Komi Republic.
February 2011 – June 2012 – Head of Department, Obstetrics and Gynecology Department (offers a course of pediatrics), Kirov State Medical Academy under the Ministry of health Care of the Russian Federation, Syktyvkar.
July 2012 – March 2013 – Deputy Head, Federal Service for Health Care Supervision, Moscow.
July 2013 – July 2015 – acting Head, Federal Service for Health Care Supervision.
July 14, 2015 till present time – Head of the Federal Service for Health Care Supervision (has the title of the Full State 2-nd Class Counsellor of the Russian Federation).
1999 – Doctor of Medicine.
2004 – postgraduate degrees in Obstetrics/Gynecology and Public Health Care Administration.
Board certified in Obstetrics/Gynecology and Public Health Care Administration.
Editor-in-Chief and Founder, Human Health in the North Journal. Editorial Board Member, Children’s Health Care in the North West Journal.
Aleksandr Petrov — Deputy, Member of the Committee on Health Protection, State Duma of the Federal Assembly of the Russian Federation
Sergey Tsyb — Deputy Minister of Industry and Trade of the Russian Federation
Date of birth: 29 April 1968
Place of birth: Obninsk, Kaluga Region
Education: Graduated from G.V. Plekhanov Russian Academy of the Economics, PhD in Economics
Work history:
1991–2007: Executive positions in various businesses
2007–2008: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Energy of the Russian Federation
2008–2013: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Trade of the Russian Federation
Since 2013: Deputy Minister of Industry and Trade of the Russian Federation
Awards:
2009: Mercy honorary badge from the Ministry of Healthcare and Social Development of the Russian Federation
2011: Honorary Chemist title from the Ministry of Industry and Trade of the Russian Federation
2011: Prize of the Government of the Russian Federation in the field of science and technology for development and implementation of the scientific fundamentals of the national system of chemical product turnover safety
2015: Medal of the Service to the Motherland Order 2nd Degree
Civil rank: Full State Councillor of the Russian Federation, 1st Class
Vladimir Chekhonin — Vice President, Russian Academy of Sciences; Head of the Department of Medical Nanobiotechnology of Medical and Biological Faculty, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation
Vladimir Chekhonin, born 1959.
1975-1981 studied and graduated from the Therapeutic faculty of Pirogov Russian National Research Medical University. In 1984 received a PhD (Candidate of Sciences Degree) the Biochemistry Department of the same University.
My career at the Pirogov University began with the position of junior fellow at the
Problem Laboratory for Immunochemistry of Malignant and Embryonic Tissues at the Biochemistry Department.
Since 1986 my work has been connected with the Serbsky State Scientific Center for Social and Forensic Psychiatry. At the Center, I worked as senior fellow, leading the immunochemistry group and Head of the Immunochemistry Lab. Currently working as Director of the Department of Fundamental and Applied Neurobiology at the Serbsky Center.
In 1989 I received a Doctoral Degree (Doctor of Sciences) in Biochemistry. Graduated from the International school of Neuroscience (Padova, Italy) in 1992. In 1993 I was awarded the title of Professor of Biochemistry by the Higher Attestation Commission of Russia.
Elected corresponding member of the Russian Academy of Medical Sciences in 2002, became full member in 2005. Since 2011 – Secretary Academician of the Medical and Biological Department of the Russian Academy of Medical Sciences.
In 2008 founded the Department of Medical Nanobiotechnologies at the Russian State Medical University.
Since 2013 – member of the Russian Academy of Sciences and member of the RAS Presidium.
Elected Vice-President of the Russian Academy of Sciences in 2017.
Over 350 research publications, including 23 inventions and patents in Russia and 7 monographs published in Russia and abroad.
Awards
Laureate of the Pirogov Russian National Research Medical University Gulevich Prize for the best paper on Biochemistry and Medical Chemistry
Medal of the Order ‘For Merit to the Fatherland’, II class (2001)
Honoured Scholar of the Russian Federation (2007)
Badge for Contributions to Healthcare (2013)
Gold Medal of Pirogov Russian National Research Medical University (2015)
Vladimir Shipkov — Executive Director, Association of International Pharmaceutical Manufacturers (AIPM)
Education:
1974 г. – Military Institute of Foreign Languages
1991 г. – Russian State Humanities University
Professional activity
For a long time Mr. Shipkov has worked in the different governmental institutions. He has a deep knowledge and understanding of governmental functioning, as well as a wide range of contacts that contribute to the execution of the assigned duties in AIPM. His career of the government em-ployee includes, among other, the functions of the Director of Pharmaceutical Inspection of the Ministry of Healthcare of the Russian Federation, Deputy Director of the Federal Service of Intel-lectual Property, Patents and Trademarks (Russian Agency for Patents and Trademarks). Mr. Ship-kov also has working experience in the State Duma of the Russian Federation, State Customs Committee of the Russian Federation, banking sector. He served on actual military service.
Since 2007 he is heading of the Association of International Pharmaceutical Manufacturers.
Front row participants:
Konstantin Baranov — Minister of Healthcare of the Kaluga Region
Yury Zhulev — President, Russian Haemophilia Society
Yury Krestinskiy — Director, Centre for Healthcare Development, Moscow School of Management SKOLKOVO
Since 2016: head of research centre for economics and management in healthcare at the Skolkovo management school in Moscow. The centre's primary objective is to conduct research on effective management, economics and informational support for Russia's healthcare system and to create and implement educational programmes promoting development of professional healthcare managers. Since 2007: Director of Institute of Public Healthcare Development. Key recent project: Moscow Medical Cluster. 1993 foundation of the Bionika group, CEO. 2007: headed the Department of Pharmaceutical Activities, Regional and Information Policy at the Ministry of Health and Social Development of the Russian Federation. Apart from the activities covered by the name of the department, supervised development of high-tech medical care in the Russian Federation and engaged foreign specialists. Civil engagement: Since 2003: member of the coordinating council of the Russian Association of Pharmacy Chains. Since 1999: co-chairman of the coordinating council of the Russian Association for Pharmaceutical Marketing. 1995–2002: Association of Commercial Pharmaceutical Organizations PharmAsk, Deputy CEO. Works with the Institute of Public Healthcare Development and various professional committees under different government agencies. Has a versatile investment portfolio including projects in film, fitness (he is also an instructor in qigong and tai chi), fresh water supply, R&D of new medical products, venture projects, etc. Promotes young entrepreneurs. Has five children.
Vadim Kukava — Executive Director, Association of Pharmaceutical Companies "Innovative Pharma"
In 2012, Vadim Kukava was offered the position of Executive Director of the Association of leading global innovative pharmaceutical companies, InPharma. During this time, the Association has become a key player in the Russian pharmaceutical market, collaborating with government bodies to develop balanced regulations of the industry for the benefit of Russian patents.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.
Natalia Nikitenko — Director, Life Science and Health Group in the CIS, EY
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Irina Panarina — General Manager, AstraZeneca Russia and Eurasia
Since May 2017 Irina Panarina has been appointed to the position of General Manager of AstraZeneca, Russia and Eurasia. Irina is responsible for AstraZeneca business in Russia & Eurasia Area and she leads AstraZeneca Russia.
Irina Panarina has worked for AstraZeneca since 2009. In October 2015 Irina joined the Russian team as Cardiovascular and Metabolic Disease Business Unit Head. Before coming to Russia, Irina Panarina held the position of General Manager at AstraZeneca Ukraine.
Prior to joining AstraZeneca Irina held regional roles at GSK Pharma headquarters in London, UK.
Irina Panarina has work experience in marketing, product portfolio management, people development.
Irina Panarina has degrees from Newcastle University & South Bank University. She also holds MBA degree from INSEAD Business School.
Vladislav Shestakov — Director, State Institute of Drugs and Good Practices
Shestakov, Vladislav (born on November 27, 1969, in Salekhard, USSR) is a Director of State Institute of Drugs and Good Practices, Deputy Director of Russian State GMP-Inspectorate.
Before being appointed as a Director of the Institute served as Chairman of the Pharmacy and Biotechnology branch offices of All Russia Public Organization “Business Russia”.
Honorary chemist, a certified inspector and GMP auditor. Russian State GMP-Inspectorate Deputy Head and Head of the GP Committee of the Pharmacy vocational qualifications Council of the National Pharmaceutical Chamber. Since 1997 has been working in the field of healthcare and pharmacy.
Biography
Born on November 27, 1969 in Salekhard, Yamalo-Nenets Autonomous area, USSR. In 1987 he entered the Tyumen State Medical Institute, in 1989 he continued his studies at the Smolensk State Medical Academy. He graduated from the State University of Management (2005), specialty – “State and municipal management”. In 2008 he graduated from the Academy of Labor and Social Relations, “Business Administration”. In 2016 he got a vocational retraining diploma of the Moscow Institute of Physics and Technology (MIPT), "GMP and drugs quality control - theory and practice of GMP-inspection / audit."
2000 - Deputy Director-General, Irbitsky Chemical and Pharmaceutical Plant.
2001-2001 - Vice-president, Rosmedprom.
2002-2003 - Head of commercial department, Hemofarm, Moscow office.
2004-2005 - Deputy Director-General, Makiz-Pharma.
2005 - General Director, Skopinsky Pharmaceutical Plant.
2007 – GR Director, Union of Professional Pharmaceutical Organizations.
2008 – President, Epidbiomed Group of Companies.
2009 - Business Development Director, Binnopharm.
2011-2012 – Counselor to the Director-General, Usolie-Sibirskiy Khimfarmzavod.
2012-2013 – Deputy Director-General, Nanolek.

On November 27, 2013, Shestakov was appointed as Director of State Institute of Drugs and Good Practices.
Since 2003, he has been a regular lecturer of educational programs for professional development in the field of managing the commercial and government organizations’ activities, as well as specialized programs in pharmaceuticals and pharmaceutical production. He has the certificate of the international inspector of WHO on good manufacturing practice.
Awards
• The title of “Honorary Chemist”
• Certificate of Honor from the Minister of Industry and Trade of the Russian Federation “For achieved progress at work”.
 14:30–16:00
 Conference hall 9
Broadcast
Personalized Medicine: Could Scientific Research Become a Successful Business? Panel session The contribution of healthcare to quality of life In April 2018, the Ministry of Health of the Russian Federation approved a concept of predictive, preventive, participatory, and personalized medicine, or P4 medicine. Today, it is seeing rapid growth in many countries, and the market for these services is increasing by 30% on average every year. The public–private partnership mechanism is an effective tool for implementing the concept. As global experience shows, collaboration between the state and business in various projects to modernize the healthcare system is more productive. In Russia, the integration of private investors into public healthcare is still in the early stages. Is it possible to develop personalized medicine in Russia through public–private partnerships? What form might financial models for attracting private capital to the healthcare system take? What P4 medicine services are likely to be developed in the near future?
Moderator:
Mikhail Paltsev — Director, Immunology and Molecular Medicine Center, Lomonosov Moscow State University
Mikhail Paltsev was born on November 9, 1949 in Moscow.He graduated from Sechenov 1st Moscow Medical Institute in 1972. 1987 to 2009: President, Sechenov Moscow Medical Academy.2006 to 2011: First Vice President, Russian Academy of Medical Sciences.2011 to present: Deputy Director for Medical and Biological Research, Kurchatov Institute National Research Centre.2015 to 2017: Acting Chief Academic Secretary, Presidium of the Russian Academy of Sciences. Corresponding member of the Russian Academy of Medical Sciences since 1991, full member of the Russian Academy of Medical Sciences since 1994, full member of the Russian Academy of Sciences – Medical Sciences Division since 1997. Since 2016 - Director of Academic Research Center of Financial University under the Government of the Russian Federation. Mikhail Paltsev is a specialist in the field of functional morphology. He has been among the pioneers of new scientific areas in Russia: molecular medicine and predictive, preventive and personalized medicine. His research concerns the search for molecular markers of socially important diseases, development of advanced diagnostic methods, development of new-generation drugs, and modern techniques and principles for treating diseases using gene and cell technology. He has authored more than 600 papers, including some 80 monographs, manuals, textbooks and atlases, and made 25 inventions. A member of the Presidium of the Russian Academy of Sciences, the Inter-Agency Council on Awarding Russian Federation Government Prizes in the Field of Science and Technology, and the Russian Accreditation Council. A national representative in the European Association for Predictive, Preventive and Personalized Medicine (ЕРМА). He has received the USSR State Prize, Russian Federation President’s Prize, and Russian Federation Government Prize (four times). He has received a commendation from the President of the Russian Federation. Mikhail Paltsev has also received the Order of Sign of Honour, Order of Friendship and Order of Merit to the Motherland, 4th Degree.
Panellists:
Andrey Vasiliev — Director, Koltzov Institute of Developmental Biology of Russian Academy of Sciences
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge "excellence in health care".
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Dmitry Kudlay — General Director, Generium JSC
Sergey Kutsev — Director, Research Centre for Medical Genetics FSBSI; Head, Molecular and Cellular Genetics Department, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation; President, Russian Medical Geneticists' Association
Andrey Lisitsa — Director, Institute of Biomedical Chemistry; Member of the Russian Academy of Sciences
Lisitsa Andrey - Dr Sc, Full member of the Russian Academy of Sciences. In 1999 he graduated from the Medical and Biological Faculty of Pirogov Russian National Research Medical University. In 2007 he presented his doctoral thesis in the specialty "bioinformatics". Since 1995 he has been working in Orekhovich Research Institute of Biomedical Chemistry (IBMC), since 2015 he holds the position of director.
Since 2014 Andrey Lisitsa has been a member of President’s Council for Science and Education, head of the expert group of the Coordinating Research Council of Russian Ministry of Education and Science. In 2016 he was elected to be full member of the Russian Academy of Sciences. He is a member of international consortium "Human Proteome".
Andrey Lisitsa is an expert in application of information and communication technologies for essential problems solving in the field of life sciences. He is author of over 100 scientific works, including 2 monographs and 8 patents, scientific supervisor of 7 Ph.D. theses.
In 2005 he was awarded a science and technology prize for young scientists for the creation of a knowledge base on cytochromes P450 by the Government, in 2010 his series of works "Avogadro's inverse number concept in proteomic studies" was awarded diploma of the Russian Academy of Medical Sciences for best research paper in biological and medical chemistry.
In 2016 Andrey Lisitsa was granted with a distinction "Honored Worker of Science and Technology of the Russian Federation".
Dmitry Sychev — Vice Rector for Development and Innovations, Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
Front row participants:
Sergey Issers — First Deputy Director, State Research Institute of Highly Pure Biopreparations of the Federal Medical-Biological Agency
Ivan Ozhgikhin — Deputy General Director for Development of Sales, Marketing and Service Support Systems for Civil Products, Shvabe JSC
Philipp Paleev — Deputy General Director for Scientific and Analytical Work, National Medical Research Center of Cardiology of the Ministry of Healthcare of the Russian Federation FSBI
Natalya Polushkina — Vice President, Executive Director, Biomedical Cluster, Skolkovo Foundation
Igor Khatkov — Chief Non-Staff Specialist Oncologist, Moscow City Healthcare Department